Other endocrine disorders

E4_ENDODIS

endocrine system disease: A disease involving the endocrine system.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E34, E35 Cause of death: ICD-10 — E34, E35 2 out of 7 registries used, show all original rules.	2051
4. Check minimum number of events None	2051
5. Include endpoints E4_CARCISDR E4_HYPERSEC E4_ECTHOR E4_SHORT E4_TALL E4_ANDRORESIST E4_ENDODISNAS E4_ENDINOTH	2167
6. Filter based on genotype QC (FinnGen only)	2167

Control definitions (FinnGen only)

Control exclude: E4_ENDOGLAND

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	E4_ENDODIS
CONTROL_EXCLUDE	E4_ENDOGLAND
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	E4_CARCISDR\|E4_HYPERSEC\|E4_ECTHOR\|E4_SHORT\|E4_TALL\|E4_ANDRORESIST\|E4_ENDODISNAS\|E4_ENDINOTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E3[4-5]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E3[4-5]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other endocrine disorders based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	31129	16403	14689
Only index persons	22605	12208	10397
Unadjusted period prevalence (%)
Whole population	0.44	0.47	0.41
Only index persons	0.42	0.45	0.40
Median age at first event (years)
Whole population	7.81	8.09	7.35
Only index persons	10.77	11.10	10.40

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2167	1294	873
Unadjusted period prevalence (%)	0.42	0.44	0.38
Median age at first event (years)	15.85	15.95	15.70

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1937: Matched controls
18807

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

E34.35

ICD-10 Finland

Abnormal growth retardation

1301.2

323.0

421

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

+∞

323.0

558

E34.0

ICD-10 Finland

Carcinoid syndrome

+∞

291.2

275

H01AC01

ATC

somatropin; parenteral

1448.0

269.3

259

E34.39

ICD-10 Finland

Short stature, not elsewhere classified

930.0

258.8

251

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

21.1

217.5

334

184

E34.30

ICD-10 Finland

Short stature NOS

+∞

206.9

197

101

Kela drug reimbursment

Anterior pituitary hypofunction

+∞

189.8

181

E23.01

ICD-10 Finland

Isolated deficiency of growth hormone

+∞

137.7

132

H01CB02

ATC

octreotide; parenteral

170.3

124.5

131

186

Kela drug reimbursment

Growth retardation associated with renal failure (growth hormone)

+∞

110.3

106

E34.40

ICD-10 Finland

Constitutional tall stature

+∞

108.2

104

301

Kela drug reimbursment

Growth hormone

530.7

104.5

104

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

97.9

102.9

114

H01CB03

ATC

lanreotide; parenteral

195.9

92.1

E34.45

ICD-10 Finland

Abnormal growth increase

428.6

84.8

E34.31

ICD-10 Finland

Short stature, prenatal disorder

829.0

83.2

130

Kela drug reimbursment

Malignant tumour

6.1

82.0

241

428

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

49.8

76.2

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

259.5

75.1

H02AB09

ATC

hydrocortisone; systemic

7.4

69.6

175

249

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

224.3

64.8

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

63.0

64.0

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

14.1

57.8

101

25898

ICD-8 Finland

Polyglandular dysfunction and other diseases of endocrine glands, Alii definiti

+∞

56.9

R62.8

ICD-10 Finland

Other lack of expected normal physiological development

18.1

56.2

E23.02

ICD-10 Finland

Neurosecretory dysfunction of the growth hormone

+∞

55.9

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

4.8

55.4

197

431

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

+∞

54.8

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

8.1

54.3

127

161

H03AA01

ATC

levothyroxine sodium; systemic

2.6

53.2

451

1936

E23.00

ICD-10 Finland

Panhypopituitarism

+∞

52.8

C17.2

ICD-10 Finland

Malignant neoplasm: Ileum

111.9

51.4

JN4CD

NOMESCO Finland

Very extensive body CT

8.5

50.4

114

137

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

50.0

49.4

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

4.8

48.2

170

367

25899

ICD-8 Finland

Polyglandular dysfunction and other diseases of endocrine glands, Other and unspecified diseases of endocrine system

+∞

47.6

8240/3-C17.9

ICD-O-3

Neuroendocrine tumor, NOS, of small intestine, NOS

238.6

46.6

WX408

NOMESCO Finland

General anesthesy, balanced

2.2

46.5

626

3360

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

101.6

46.4

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

45.3

767

4534

JFB00

NOMESCO Finland

Partial resection of small intestine

11.0

44.6

E34.3

ICD-10 Finland

Short stature, not elsewhere classified

+∞

44.5

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.3

42.4

230

729

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

5.7

41.9

125

223

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.5

41.0

375

1652

E34.8

ICD-10 Finland

Other specified endocrine disorders

+∞

39.3

JN4BD

NOMESCO Finland

Extensive body CT

3.3

38.7

210

664

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

38.1

499

2604

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.3

38.1

411

1962

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

7.2

37.6

132

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.3

35.8

195

617

E30.00

ICD-10 Finland

Familial delayed puberty

353.1

35.7

E30.09

ICD-10 Finland

Delayed puberty NOS

353.1

35.7

D77

ICPC

Malignant digestive neopl other/NOS

39.7

34.9

JN4AD

NOMESCO Finland

Body CT examination

3.8

34.2

153

413

Z31.5

ICD-10 Finland

Genetic counselling

3.3

34.2

182

566

L01AX03

ATC

temozolomide; systemic

27.5

34.2

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

23.2

34.0

XX3DW

NOMESCO Finland

Time consuming IT work

3.0

32.3

199

685

SPAT1262

SPAT

Handing over of treatment supplies

2.4

31.3

308

1391

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.4

31.2

161

488

JN7AN

NOMESCO Finland

Somatostatin receptor isotope imaging

+∞

31.0

602

Kela drug reimbursment

Children's severe malnutrition

5.8

30.6

154

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

16.8

30.5

302

Kela drug reimbursment

Interferon alfa

157.8

30.4

UJF32

NOMESCO Finland

Coloscopy

2.1

29.4

397

2069

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

152.8

29.4

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.0

29.3

466

2595

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

16.7

29.2

A11CC03

ATC

alfacalcidol; systemic

6.5

28.6

117

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.8

28.6

757

5016

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.0

28.3

120

309

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

277.0

27.5

AA4CM

NOMESCO Finland

Extensive MRI examination of sella turcica with 3 Tesla magnet

142.8

27.4

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.0

27.3

446

2497

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.5

26.9

235

994

A03FA01

ATC

metoclopramide; systemic, rectal

2.1

26.7

332

1664

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

26.4

710

4694

JN7SN

NOMESCO Finland

Somatostatin receptor SPECT

+∞

25.8

106

Kela drug reimbursment

Hypoparathyroidism

+∞

25.8

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.1

25.8

348

1802

E22.1

ICD-10 Finland

Hyperprolactinaemia

71.5

25.5

T73

ICPC

Neoplasm endocrine other/unspecified

91.9

25.4

A09AA02

ATC

multienzymes (lipase, protease etc.)

7.8

24.4

C17.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of small intestine

245.8

24.4

E21.0

ICD-10 Finland

Primary hyperparathyroidism

127.8

24.3

105

Kela drug reimbursment

Adrenal cortical hypofunction

+∞

23.7

E22.80

ICD-10 Finland

Central precocious puberty

235.7

23.4

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.4

23.2

116

343

BF20A

NOMESCO Finland

+∞

22.7

JN3AD

NOMESCO Finland

Abdominal CT examination

3.1

22.5

133

443

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

6.0

22.5

105

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.5

21.9

190

796

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.4

21.9

203

881

L03AB05

ATC

interferon alfa-2b; parenteral

23.5

21.8

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

215.8

21.4

8240/3-C17.2

ICD-O-3

Neuroendocrine tumor, NOS, of ileum

215.8

21.4

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.6

21.3

677

4625

JFB30

NOMESCO Finland

Right hemicolectomy

8.9

21.1

C10AC01

ATC

colestyramine; oral

5.2

20.9

127

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.1

20.4

116

377

A02BC01

ATC

omeprazole; systemic

1.8

20.4

406

2406

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

4.5

20.3

162

A12AA04

ATC

calcium carbonate; oral

7.4

20.2

RD210

NOMESCO Finland

3.4

20.1

102

306

J01MA12

ATC

levofloxacin; systemic

2.1

19.9

259

1310

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

8.2

19.7

R50.9

ICD-10 Finland

Fever, unspecified

1.9

19.6

341

1927

104

Kela drug reimbursment

Thyroid insufficiency

3.0

19.6

114

378

E30.1

ICD-10 Finland

Precocious puberty

196.0

19.3

N02AA05

ATC

oxycodone; systemic

2.3

19.3

184

809

JKA20

NOMESCO Finland

Cholecystectomy

5.8

19.2

R62.0

ICD-10 Finland

Delayed milestone

3.4

19.0

272

A04AA02

ATC

granisetron; systemic, transdermal

3.2

18.7

103

329

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.5

18.6

255

E22.0

ICD-10 Finland

Acromegaly and pituitary gigantism

+∞

18.6

NH3EA

NOMESCO Finland

Feet X-ray examination with load

5.5

18.4

100

Z51.80

ICD-10 Finland

Manipulation of puberty development with hormone therapy

186.1

18.3

127

Kela drug reimbursment

Transplant complication

4.7

18.3

130

B03BA03

ATC

hydroxocobalamin; parenteral

3.4

18.2

260

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

7.6

17.9

7834C

ICD-9 Finland

Symptoms concerning nutrition, metabolism and development, Lack of expected normal physiological development[HÄIRIINTYNYT PITUUSKASVU]

32.2

17.7

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.5

17.7

147

604

102

Kela drug reimbursment

Diabetes insipidus

+∞

17.5

C03CA01

ATC

furosemide; systemic

1.9

17.5

305

1722

WX723

NOMESCO Finland

CPAP therapy

4.1

17.4

164

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

8.0

17.3

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

4.4

17.2

143

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

16.7

336

1985

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

+∞

16.5

E34.1

ICD-10 Finland

Other hypersecretion of intestinal hormones

+∞

16.5

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

5.2

16.5

121

Kela drug reimbursment

Severe hypofunction of sexual glands

5.5

16.5

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.9

16.4

100

343

E26.0

ICD-10 Finland

Primary hyperaldosteronism

166.3

16.3

8249/3-C17.9

ICD-O-3

Neuroendocrine tumor, grade 2 of small intestine, NOS

166.3

16.3

XX9AD

NOMESCO Finland

Complementary CT

166.3

16.3

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

4.4

16.3

133

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

4.1

16.1

153

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

8.8

16.1

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

16.0

254

1382

L01BC06

ATC

capecitabine; oral

3.9

15.9

164

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

15.5

370

2297

E30.9

ICD-10 Finland

Disorder of puberty, unspecified

+∞

15.5

8246/3-C17.9

ICD-O-3

Neuroendocrine carcinoma, NOS, of small intestine, NOS

+∞

15.5

E34.5

ICD-10 Finland

Androgen resistance syndrome

+∞

15.5

XFE00

NOMESCO Finland

Epicardial ultrasonography

4.3

15.4

131

BCA31

NOMESCO Finland

Endoscopic unilateral adrenalectomy

25.7

15.4

JAH00

NOMESCO Finland

Laparotomy

3.9

15.3

165

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

156.5

15.3

E21.3

ICD-10 Finland

Hyperparathyroidism, unspecified

37.2

15.2

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

5.3

15.1

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.8

15.1

276

1576

UKC02

NOMESCO Finland

Cystoscopy

2.1

15.0

189

941

G02CB01

ATC

bromocriptine; systemic

6.4

15.0

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

5.5

15.0

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

22.9

14.9

WZC30

NOMESCO Finland

Teaching

2.0

14.8

204

1053

T99

ICPC

Endocr/metab/nutrit disease other

5.8

14.6

D44.8

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement

+∞

14.4

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.0

14.4

206

1077

C17.0

ICD-10 Finland

Malignant neoplasm: Duodenum

78.3

14.4

SPAT1377

SPAT

Polysomnography

3.7

14.3

170

JN4DD

NOMESCO Finland

Scout CT scan of torso

35.2

14.2

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.1

14.1

172

846

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

13.9

425

2811

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

6.6

13.9

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.7

13.8

161

-50

ICPC

Medication/prescr/renewal

3.0

13.7

273

TPH07

NOMESCO Finland

Cathetrisation of artery

2.0

13.7

189

977

L04AA01

ATC

[U] ciclosporin; systemic

5.4

13.5

A12AA06

ATC

calcium lactate gluconate; oral

136.8

13.3

L04AA06

ATC

mycophenolic acid; systemic

4.0

13.3

132

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.1

13.2

148

702

N04BC06

ATC

cabergoline; oral (dopamine agonists)

20.7

13.1

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

13.0

324

2027

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.2

12.9

136

627

F82

ICD-10 Finland

Specific developmental disorder of motor function

3.7

12.8

146

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

6.7

12.8

E83.50

ICD-10 Finland

Hypercalcemia

7.7

12.8

H02AA02

ATC

fludrocortisone; oral

10.7

12.8

E27.0

ICD-10 Finland

Other adrenocortical overactivity

68.2

12.4

XF404

NOMESCO Finland

Ambulatory ECG

2.1

12.4

151

743

2592A

ICD-9 Finland

Other endocrine disorders, Carcinoid syndrome

+∞

12.4

BB1BQ

NOMESCO Finland

Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT

+∞

12.4

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

+∞

12.4

2594A

ICD-9 Finland

Other endocrine disorders, Dwarfism, not elsewhere classified

+∞

12.4

E23.6

ICD-10 Finland

Other disorders of pituitary gland

+∞

12.4

UDC00

NOMESCO Finland

Ear microscopy

2.0

12.1

153

763

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

4.5

12.1

-44

ICPC

Preventive immunization/medic

2.1

12.1

140

675

N06AA09

ATC

amitriptyline; systemic

2.2

12.0

126

581

J45.1

ICD-10 Finland

Nonallergic asthma

2.0

12.0

156

785

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.1

11.9

143

699

A02BC05

ATC

esomeprazole; systemic

1.5

11.9

511

3645

SPAT1325

SPAT

Vaccination

1.4

11.8

642

4805

R4190

NOMESCO Finland

Nutritional therapy

2.0

11.8

148

735

B81

ICPC

Anaemia vit B12/folate deficiency

3.4

11.8

168

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.0

11.6

110

A02BA02

ATC

ranitidine; systemic

1.8

11.5

225

1310

WX780

NOMESCO Finland

Remote monitoring CPAP

3.1

11.5

198

E28.3

ICD-10 Finland

Primary ovarian failure

63.4

11.5

G47.3

ICD-10 Finland

Sleep apnoea

1.7

11.4

244

1460

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

11.4

227

1329

E24.0

ICD-10 Finland

Pituitary-dependent Cushing disease

+∞

11.3

8240/3-C34.9

ICD-O-3

Neuroendocrine tumor, NOS, of lung, NOS

+∞

11.3

E35.8

ICD-10 Finland

Disorders of other endocrine glands in diseases classified elsewhere

+∞

11.3

E25.01

ICD-10 Finland

Congenital adrenal hyperplasia

+∞

11.3

321

Kela drug reimbursment

Paricalcitol and cinacalcet

117.1

11.3

E21.1

ICD-10 Finland

Secondary hyperparathyroidism, not elsewhere classified

117.1

11.3

WX402

NOMESCO Finland

General anaesthesia

1.6

11.3

321

2075

R11

ICD-10 Finland

Nausea and vomiting

1.9

11.3

176

953

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

9.0

11.2

N02AX02

ATC

tramadol; systemic, rectal

1.5

11.2

508

3658

205

Kela drug reimbursment

Chronic hypertension

1.7

11.2

277

1726

C17.1

ICD-10 Finland

Malignant neoplasm: Jejunum

34.2

11.1

BCA30

NOMESCO Finland

Unilateral adrenalectomy

34.2

11.1

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

2.7

11.1

264

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

6.8

11.1

SPAT1153

SPAT

Removal of sutures

1.5

11.0

419

2899

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

16.6

11.0

R06.0

ICD-10 Finland

Dyspnoea

1.6

11.0

328

2147

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

24.4

11.0

B01AB10

ATC

tinzaparin; parenteral

2.4

10.9

400

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

6.6

10.9

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

5.3

10.9

F83

ICD-10 Finland

Mixed specific developmental disorders

2.9

10.8

233

N06AX16

ATC

venlafaxine; oral

1.8

10.8

207

1200

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

10.8

297

1905

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

5.9

10.8

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

4.3

10.7

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

3.0

10.7

207

SPAT1324

SPAT

Screening procedure

0.5

10.6

1429

H02AB06

ATC

prednisolone; systemic

1.4

10.6

645

4907

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

27.3

10.6

Z56.5

ICD-10 Finland

Uncongenial work

27.3

10.6

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

10.3

10.6

JF1BD

NOMESCO Finland

Very extensive small bowel CT

8.6

10.5

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

3.7

10.5

121

Z01.9

ICD-10 Finland

Special examination, unspecified

2.4

10.5

371

Z94.0

ICD-10 Finland

Kidney transplant status

4.3

10.5

E29.1

ICD-10 Finland

Testicular hypofunction

12.6

10.4

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

10.4

181

1018

Z87.6

ICD-10 Finland

Personal history of certain conditions arising in the perinatal period

2.9

10.3

202

E23.03

ICD-10 Finland

Lack of ACTH

+∞

10.3

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

3.4

10.2

139

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

10.2

328

2181

C18.19

ICD-10 Finland

Malignant tumor in appendix other or unspecified histology

15.6

10.2

RL140

NOMESCO Finland

4.9

10.2

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

10.2

132

667

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.0

10.1

132

668

E87.6

ICD-10 Finland

Hypokalaemia

3.4

10.1

141

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

6.9

10.0

H05BX01

ATC

cinacalcet; oral

39.0

9.8

A11CC02

ATC

dihydrotachysterol; oral

39.0

9.8

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

9.8

758

5992

SPAT1312

SPAT

General health counselling

1.4

9.8

680

5278

A06AD11

ATC

lactulose; oral

1.8

9.8

165

917

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.0

9.7

127

644

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

5.9

9.7

K03.66

ICD-10 Finland

Tooth plaque

1.8

9.7

168

938

C25.2

ICD-10 Finland

Malignant neoplasm: Tail of pancreas

25.4

9.7

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

9.7

164

912

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.9

9.6

134

697

Q87.88

ICD-10 Finland

Other specified congenital malformation syndromes, not elsewhere classified

8.5

9.6

JFB20

NOMESCO Finland

Ileocaecal resection

9.3

9.6

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

9.5

139

734

158

Kela drug reimbursment

Everolimus

53.6

9.5

E23.2

ICD-10 Finland

Diabetes insipidus

53.6

9.5

Z51.5

ICD-10 Finland

Palliative care

2.6

9.5

261

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

4.1

9.5

WX110

NOMESCO Finland

Local anesthesy

1.4

9.4

1248

10727

L04AD01

ATC

ciclosporin; systemic

3.1

9.4

154

ZXA10

NOMESCO Finland

Bilateral

1.6

9.3

292

1928

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.7

9.3

233

P05.1

ICD-10 Finland

Small for gestational age

6.2

9.3

D44.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Endocrine gland, unspecified

97.5

9.3

E27.5

ICD-10 Finland

Adrenomedullary hyperfunction

97.5

9.3

E340, C179

ICD-10 Finland

+∞

9.3

8240/3-C20.9

ICD-O-3

Neuroendocrine tumor, NOS, of rectum, NOS

+∞

9.3

2520A

ICD-9 Finland

Disorders of parathyroid gland, Hyperparathyroidism

+∞

9.3

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.8

9.2

212

WX400

NOMESCO Finland

Inhalation anesthesy

2.0

9.2

115

574

A41.9

ICD-10 Finland

Sepsis, unspecified

2.6

9.2

260

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

7.3

9.2

A55

ICPC

General and Unspecified, Local injection/infiltration

6.4

9.2

WZA10

NOMESCO Finland

Long statement of health and health related matters

3.7

9.2

100

ZX120

NOMESCO Finland

Intravenous

1.8

9.2

151

832

C03DA01

ATC

spironolactone; oral

1.9

9.1

130

679

R68.8

ICD-10 Finland

Other specified general symptoms and signs

5.7

9.1

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.1

9.1

107

520

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.5

9.0

267

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

3.0

9.0

159

A02BC02

ATC

pantoprazole; systemic

1.3

9.0

828

6702

XKC03

NOMESCO Finland

Water cystometry

3.1

9.0

154

B01AB05

ATC

enoxaparin; parenteral

1.5

9.0

348

2412

SPAT1301

SPAT

No procedures

1.4

8.9

531

3995

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

3.1

8.9

150

E0000UV

ATC

1.4

8.9

704

5561

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.8

8.8

164

938

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

8.8

231

1458

JLC10

NOMESCO Finland

Distal pancreatectomy

18.1

8.8

D76

ICPC

Malignant neoplasm pancreas

23.4

8.8

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

8.8

135

728

SPAT1263

SPAT

Sampling

1.3

8.6

726

5784

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.1

8.6

101

490

N03AX16

ATC

pregabalin; oral

1.6

8.6

265

1742

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

3.0

8.6

154

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.4

8.6

312

8249/3-C17.2

ICD-O-3

Neuroendocrine tumor, grade 2 of ileum

48.7

8.6

Q87.19

ICD-10 Finland

Congenital malformation syndromes predominantly associated with short stature

48.7

8.6

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

8.6

196

1195

L04AX01

ATC

azathioprine; systemic

2.2

8.5

398

137

Kela drug reimbursment

Uraemia requiring dialysis

5.0

8.5

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.9

8.4

B03XA01

ATC

erythropoietin; parenteral

5.1

8.4

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

5.3

8.4

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

8.4

695

5520

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

8.7

8.3

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

8.3

275

1834

AA1AD

NOMESCO Finland

CT of head and brain

1.5

8.3

262

1730

C07AB02

ATC

metoprolol; systemic

1.6

8.3

215

1352

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

87.8

8.3

E21.2

ICD-10 Finland

Other hyperparathyroidism

87.8

8.3

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

8.3

163

952

R5140

NOMESCO Finland

Monitoring the use of the aid

1.9

8.3

120

634

K85

ICD-10 Finland

Acute pancreatitis

4.6

8.3

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.5

8.3

257

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

8.3

125

670

OAB72

NOMESCO Finland

Weight control and weight loss guidance

7.1

8.2

G44.2

ICD-10 Finland

Tension-type headache

1.6

8.2

196

1207

8249/3-C25.9

ICD-O-3

Neuroendocrine tumor, grade 2 of pancreas, NOS

+∞

8.2

E24.9

ICD-10 Finland

Cushing syndrome, unspecified

+∞

8.2

E20.8

ICD-10 Finland

Other hypoparathyroidism

+∞

8.2

E83.51

ICD-10 Finland

Hypocalcemia

12.4

8.2

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

8.2

206

1288

A07AA02

ATC

nystatin; oral

2.2

8.1

374

BC00A

NOMESCO Finland

9.2

8.1

JAH01

NOMESCO Finland

Laparoscopy

2.3

8.1

303

F59

ICD-10 Finland

Unspecified behavioural syndromes associated with physiological disturbances and physical factors

5.1

8.1

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

8.1

242

1581

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.5

8.1

230

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.3

8.0

287

XX4AW

NOMESCO Finland

3.3

8.0

113

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

4.3

8.0

E23.05

ICD-10 Finland

Lack of TSH

32.5

8.0

8240/3-C18.2

ICD-O-3

Neuroendocrine tumor, NOS, of ascending colon

32.5

8.0

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

8.0

360

XA800

NOMESCO Finland

Neuropsychological investigation

1.9

7.9

105

539

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.7

7.9

150

865

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

4.2

7.9

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.6

7.8

215

1375

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.9

7.8

151

XKD00

NOMESCO Finland

Uroflowmetry

1.7

7.8

158

929

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.9

7.8

152

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

2.1

7.7

423

R53

ICD-10 Finland

Malaise and fatigue

1.5

7.7

291

2000

I15.9

ICD-10 Finland

Secondary hypertension, unspecified

6.4

7.7

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

7.7

280

1910

XF602

NOMESCO Finland

Bloodpressure monitoring

3.7

7.7

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

2.8

7.6

167

L01CB01

ATC

etoposide; systemic

10.5

7.6

C74.9

ICD-10 Finland

Malignant neoplasm: Adrenal gland, unspecified

43.8

7.6

L01XE10

ATC

[U] everolimus; oral

43.8

7.6

340

Kela drug reimbursment

Everolimus

43.8

7.6

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

7.5

121

664

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

2.8

7.5

163

S02.51

ICD-10 Finland

Fracture of tooth, open

1.8

7.5

135

767

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

5.8

7.5

T90

ICPC

Diabetes non-insulin dependent

1.6

7.5

221

1437

T10

ICPC

Growth delay

5.4

7.5

318

Kela drug reimbursment

Teriparatide

24.4

7.5

Q87.14

ICD-10 Finland

Noonan's syndrome

24.4

7.5

SPAT1260

SPAT

Consultation of another employee

1.5

7.4

277

1900

Y0099

ICD-8 Finland

Investigation of endocrine system and metabolism

8.6

7.4

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

7.4

157

938

N03AX09

ATC

lamotrigine; oral

2.0

7.3

434

E21

ICD-10 Finland

Hyperparathyroidism and other disorders of parathyroid gland

78.0

7.3

8240/3-C25.9

ICD-O-3

Neuroendocrine tumor, NOS, of pancreas, NOS

78.0

7.3

E89.6

ICD-10 Finland

Postprocedural adrenocortical(-medullary) hypofunction

78.0

7.3

K65.0

ICD-10 Finland

Acute peritonitis

5.3

7.3

N05BA04

ATC

oxazepam; oral

1.4

7.3

321

2275

F98.2

ICD-10 Finland

Feeding disorder of infancy and childhood

4.2

7.3

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

13.0

7.2

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.6

7.2

179

1522B

ICD-9 Finland

Malignant neoplasm of small intestine, including duodenum, Ileum[NEOPLASMA MALIGNUM ILEI,ALIA DEFINITA SEU NUD]

+∞

7.2

E26.9

ICD-10 Finland

Hyperaldosteronism, unspecified

+∞

7.2

E22.9

ICD-10 Finland

Hyperfunction of pituitary gland, unspecified

+∞

7.2

E34.4

ICD-10 Finland

Constitutional tall stature

+∞

7.2

E21.5

ICD-10 Finland

Disorder of parathyroid gland, unspecified

+∞

7.2

8249/3-C80.9

ICD-O-3

Neuroendocrine tumor, grade 2 of unknown primary site

+∞

7.2

BB1AN

NOMESCO Finland

Parathyroid gland isotope imaging, 1 isotope

+∞

7.2

E35.0

ICD-10 Finland

Disorders of thyroid gland in diseases classified elsewhere

+∞

7.2

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.4

7.2

222

SPAT1094

SPAT

Continuous Positive Airway Pressure

5.8

7.2

H02AB04

ATC

methylprednisolone; systemic

1.6

7.2

173

1070

N91.0

ICD-10 Finland

Primary amenorrhoea

8.1

7.2

Z99.2

ICD-10 Finland

Dependence on renal dialysis

8.1

7.2

D89.89

ICD-10 Finland

Other specified disorders involving the immune mechanism, not elsewhere classified

10.6

7.2

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.1

7.1

113

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

4.2

7.1

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

2.4

7.1

247

SPAT1310

SPAT

Counselling related to known health issue

1.3

7.1

559

4379

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

6.1

7.1

K00.40

ICD-10 Finland

Postnatal enamel hypoplasia

2.5

7.0

200

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

7.0

470

ED1AA

NOMESCO Finland

Mandipular X-ray examination

7.1

7.0

JJA20

NOMESCO Finland

Open biopsy of liver

7.7

6.9

E03

ICD-10 Finland

Other hypothyroidism

2.1

6.9

362

M03BX01

ATC

baclofen; systemic

3.8

6.9

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

6.9

284

1988

TK800

NOMESCO Finland

Hemodialysis

3.2

6.9

105

N18.8

ICD-10 Finland

Other chronic renal failure

2.9

6.9

137

N06AB04

ATC

citalopram; systemic

1.5

6.8

256

1754

YHMAS

NOMESCO Finland

4.6

6.8

TJD20

NOMESCO Finland

Change of gastrostomy tube

4.2

6.8

FM2CE

NOMESCO Finland

2.0

6.8

373

H03BB01

ATC

carbimazole; oral

2.3

6.8

241

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

3.3

6.7

WX610

NOMESCO Finland

Patient controlled analgesia

5.0

6.7

KAC00

NOMESCO Finland

Nephrectomy

5.7

6.7

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

5.3

6.7

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.2

6.7

102

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

6.7

139

825

R03AC02

ATC

salbutamol; inhalant

1.3

6.7

886

7445

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

2.4

6.7

206

E30.8

ICD-10 Finland

Other disorders of puberty

38.9

6.7

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

6.7

131

768

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

6.5

6.6

5AB14

NOMESCO Finland

6.5

6.6

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

4.7

6.6

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

16.2

6.6

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.5

6.6

189

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

2.0

6.6

370

V03AG01

ATC

sodium cellulose phosphate; systemic

4.9

6.6

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

5.9

6.6

WW500

NOMESCO Finland

Blood transfusion

2.2

6.6

301

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

5.5

6.6

A79

ICPC

Malignancy NOS

4.4

6.6

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

3.0

6.5

115

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

6.5

126

731

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.5

6.5

194

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

4.6

6.5

N06AX21

ATC

duloxetine; oral

1.7

6.5

136

810

BAA60

NOMESCO Finland

Total thyroidectomy

3.2

6.5

AA1AA

NOMESCO Finland

Head X-ray examination

4.8

6.5

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.8

6.5

108

600

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.3

6.4

223

SPAT1281

SPAT

Other administrative function

1.6

6.4

151

927

C08CA01

ATC

amlodipine; oral

1.4

6.4

327

2380

J01MA02

ATC

ciprofloxacin; systemic

1.3

6.4

438

3346

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

9.8

6.4

C01BD07

ATC

dronedarone; oral

9.8

6.4

A01AB09

ATC

miconazole; local oral

1.7

6.4

118

679

GD2SN

NOMESCO Finland

Lung ventilation SPECT

6.7

6.4

R01AD08

ATC

fluticasone; nasal

1.4

6.4

385

2884

1CB02

NOMESCO Finland

68.0

6.3

D35.1

ICD-10 Finland

Benign neoplasm: Parathyroid gland

68.0

6.3

8246/3-C80.9

ICD-O-3

Neuroendocrine carcinoma, NOS, of unknown primary site

68.0

6.3

E20.0

ICD-10 Finland

Idiopathic hypoparathyroidism

68.0

6.3

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

6.3

181

1170

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

6.3

121

702

C08CA02

ATC

felodipine; oral

1.9

6.3

473

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.2

6.3

294

197

Kela drug reimbursment

Sunitinib

13.9

6.3

SCA02

NOMESCO Finland

Analysis and advice of nutrition with regard to dentistry

1.4

6.3

339

2490

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

4.4

6.3

R4180

NOMESCO Finland

Podiatric therapy

4.4

6.3

K06.18

ICD-10 Finland

Another gingival hyperplasia

4.4

6.3

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

7.2

6.3

E000003

ATC

1.9

6.2

436

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.6

6.2

153

-1

SPAT

1.8

6.2

102

563

E23.08

ICD-10 Finland

Hypopituitarism

+∞

6.2

2522

FHL

Removal of parathyroidism or multiple parathyroidism (including removal of adenoma or total removal)

+∞

6.2

8246/3-C25.9

ICD-O-3

Neuroendocrine carcinoma, NOS, of pancreas, NOS

+∞

6.2

E35.1

ICD-10 Finland

Disorders of adrenal glands in diseases classified elsewhere

+∞

6.2

E89.30

ICD-10 Finland

Postprocedural hypopituitarism

+∞

6.2

E23.09

ICD-10 Finland

Pituitary insufficiency NOS

+∞

6.2

E20.1

ICD-10 Finland

Pseudohypoparathyroidism

+∞

6.2

E27.2

ICD-10 Finland

Addisonian crisis

+∞

6.2

R55

ICD-10 Finland

Syncope and collapse

1.7

6.2

136

822

XLA10

NOMESCO Finland

2.3

6.2

226

Z50.0

ICD-10 Finland

Cardiac rehabilitation

4.8

6.2

ZX070

NOMESCO Finland

Intensity modified radiotherapy

3.3

6.2

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

4.3

6.1

Q87.4

ICD-10 Finland

Marfan syndrome

26.0

6.1

8240/3-C16.9

ICD-O-3

Neuroendocrine tumor, NOS, of stomach, NOS

26.0

6.1

H05AA02

ATC

teriparatide; parenteral

26.0

6.1

6402

FHL

Small bowel resection

26.0

6.1

J20

ICD-10 Finland

Acute bronchitis

1.7

6.1

131

787

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.2

6.1

268

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

6.1

450

3477

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.4

6.1

280

1999

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

2.9

6.1

110

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

6.1

260

1830

SPAT1238

SPAT

Brief therapy

2.6

6.1

149

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

2.3

6.1

230

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.5

6.1

166

H52.0

ICD-10 Finland

Hypermetropia

2.2

6.0

242

L02AE02

ATC

leuprorelin; implant, parenteral

2.4

6.0

203

C07AB07

ATC

bisoprolol; oral

1.3

6.0

464

3610

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

6.0

170

1097

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.8

6.0

535

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

435

982

5.08

175.11

6.1

3.7

mmol/l

1.2

0.70

396

844

(3036481) Cortisol [Moles/volume] in Serum or Plasma

557

1548

4.32

172.47

2.9

2.1

nmol/l

316.7

364.1

5.36

533

1430

(3035637) Corticotropin [Mass/volume] in Plasma

202

252

8.40

145.67

1.8

1.5

—

(40761536) Microorganisms panel - Urine sediment

491

1418

4.02

141.95

4.4

3.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

430

1284

3.77

116.84

4.1

2.9

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

296

683

4.67

113.73

2.3

1.5

u/l

6.5

7.0

0.29

201

484

(3012501) Base excess in Blood by calculation

179

297

6.23

99.02

4.3

4.8

mmol/l

2.7

2.2

1.13

139

175

(3010421) pH of Blood

193

362

5.53

93.86

4.3

4.4

7.4

1.26

178

292

(3003458) Phosphate [Moles/volume] in Serum or Plasma

570

2319

2.85

90.60

10.1

8.4

mmol/l

1.2

0.06

539

2196

(3018418) pH of Serum or Plasma

800

3873

2.57

89.80

6.1

3.6

7.4

0.32

389

697

(3021589) Normoblasts [#/volume] in Blood

1334

8197

2.48

88.27

16.8

9.6

e9/l

0.0

0.54

1150

6534

(3015377) Calcium [Moles/volume] in Serum or Plasma

883

4545

2.47

86.12

4.5

3.1

mmol/l

2.4

0.06

827

4024

(3023323) Follitropin [Units/volume] in Serum or Plasma

294

848

3.70

82.51

2.3

1.5

iu/l

11.8

19.3

4.76

213

646

(1616796) Gas panel - Central venous blood

169

325

5.34

79.74

3.8

4.0

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

164

351

4.78

68.22

3.6

3.7

56.3

54.7

0.69

164

351

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1732

12789

2.53

64.67

5.7

3.7

pmol/l

14.9

14.6

4.86

1606

11650

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1124

6977

2.15

64.52

12.0

8.2

mmol/l

1.2

3.31

1046

6436

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

123

214

5.80

64.49

4.3

4.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

22.58

61.02

2.1

1.7

—

(40767503) Oxygen content in Capillary blood by calculation

138

282

4.96

60.55

2.8

2.5

16.9

0.05

167

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

283

964

3.10

60.14

3.4

3.3

pmol/l

4.6

4.7

0.80

253

858

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

8.22

59.37

2.4

1.7

nmol/l

0.1

0.2

1.08

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1169

7522

2.08

59.11

11.6

8.1

mmol/l

1.2

0.83

802

6586

(42870588) Differential panel, method unspecified - Blood

1019

6246

2.08

58.65

10.0

7.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

309

1131

2.90

57.70

4.0

4.2

0.5

0.26

251

(3026782) Osmolality of Urine

624

3211

2.22

56.17

3.5

2.8

mosm/kgh2o

528.1

567.2

3.64

565

2741

(3025159) Blasts/100 leukocytes in Blood

302

1114

2.87

55.48

4.4

4.7

0.1

0.4

0.39

270

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

373

1554

2.58

53.93

3.4

3.3

g/l

0.2

0.02

357

1484

(3021440) Promyelocytes/100 leukocytes in Blood

308

1177

2.77

52.81

4.3

4.6

0.1

0.30

324

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1519

11006

2.10

52.76

11.5

6.6

u/l

100.1

88.9

8.32

1446

10340

(3017181) Myelocytes/100 leukocytes in Blood

316

1235

2.71

51.83

4.3

4.5

0.8

0.03

349

(3022096) Basophils/100 leukocytes in Blood

1218

8232

1.97

50.45

10.0

7.2

0.7

0.6

0.04

1177

7778

(3017446) Testosterone [Moles/volume] in Serum or Plasma

272

1002

2.84

49.86

3.1

1.9

nmol/l

10.5

12.3

2.26

220

852

(3021387) Prolactin [Units/volume] in Serum or Plasma

252

893

2.94

49.58

2.6

1.4

mu/l

363.8

313.7

1.32

223

795

(3006504) Eosinophils/100 leukocytes in Blood

1240

8476

1.96

49.16

9.9

7.1

3.1

3.0

1.16

1192

7976

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1012

6472

1.95

48.78

4.1

2.5

nmol/l

74.6

72.9

1.20

945

5956

(3029937) Albumin [Presence] in Urine by Test strip

733

4204

2.03

48.32

4.4

3.6

estimate

0.0

0.05

426

1483

(3019069) Monocytes/100 leukocytes in Blood

1243

8533

1.95

48.30

10.2

7.3

8.6

8.3

3.05

1201

8068

(3024561) Albumin [Mass/volume] in Serum or Plasma

946

5963

1.94

47.12

8.0

5.6

g/l

36.3

36.5

0.35

867

5577

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

425

1993

2.31

46.84

3.5

2.6

21.4

22.5

0.92

378

1775

(3041096) Erythrocytes [Presence] in Urine by Automated

742

4353

1.97

45.25

4.3

2.9

—

(3002030) Lymphocytes/100 leukocytes in Blood

1266

8885

1.90

44.37

10.0

7.1

31.6

31.5

0.15

1223

8390

(3000850) Epithelial cells [#/volume] in Urine

609

3377

2.02

43.26

4.1

2.7

e6/l

6.3

6.8

0.36

551

2950

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

489

2551

2.09

40.71

2.1

1.6

pmol/l

41795342.7

19991130.7

0.32

390

2151

(3004789) Transferrin [Mass/volume] in Serum or Plasma

430

2136

2.17

40.66

3.5

2.5

g/l

2.5

2.4

0.32

397

1993

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

58.98

40.64

2.7

2.1

pmol/l

44.4

98.0

—

(3018010) Neutrophils/100 leukocytes in Blood

1235

8748

1.84

40.37

9.6

6.9

53.3

53.7

0.53

1193

8291

(3001604) Monocytes [#/volume] in Blood

1246

8869

1.83

39.88

9.7

7.0

e9/l

0.6

3.89

1117

7554

(40760892) CBC W Ordered Manual Differential panel - Blood

640

3699

1.94

39.81

5.8

4.5

—

(3006315) Basophils [#/volume] in Blood

1247

8889

1.83

39.60

9.7

7.0

e9/l

0.0

0.85

1116

7576

(3022948) Iron [Moles/volume] in Serum or Plasma

459

2360

2.11

39.59

3.5

2.5

umol/l

12.9

13.6

1.15

423

2217

(3013650) Neutrophils [#/volume] in Blood by Automated count

1364

10004

1.85

39.34

13.8

9.5

e9/l

3.8

0.21

1237

8582

(3012095) Magnesium [Moles/volume] in Serum or Plasma

450

2308

2.11

39.01

9.6

6.4

mmol/l

0.8

0.69

427

2171

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

268

1106

2.52

38.81

6.9

5.4

ng/l

73.3

66.0

0.53

226

1022

(3013115) Eosinophils [#/volume] in Blood

1275

9191

1.82

38.57

10.4

7.5

e9/l

0.2

0.69

1150

7982

(3000570) Elastase.pancreatic [Mass/mass] in Stool

146

433

3.41

38.55

1.4

ug/g

304.7

312.0

0.15

232

(4035726)

274

1149

2.48

38.33

1.7

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

145

436

3.36

37.45

2.0

1.5

—

(3019198) Lymphocytes [#/volume] in Blood

1264

9190

1.78

36.05

9.7

7.0

e9/l

2.1

0.10

1142

8029

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1826

14929

2.14

35.80

6.1

4.3

mu/l

1.8

2.0

1.30

1705

13860

(3032080) INR in Blood by Coagulation assay

793

5044

1.81

35.70

12.5

7.2

inr

1.2

0.04

458

1472

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1043

7189

1.77

35.67

10.4

6.4

umol/l

12.6

14.1

1.09

985

6724

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

666

4132

1.80

31.81

2.8

2.5

mg/l

3.1

2.8

3.17

590

3578

(40765089) Chromosome analysis panel - Blood by G-banded

110

5.55

31.78

1.0

—

(3002582) Erythrocytes [#/volume] in Urine

769

4976

1.76

31.78

4.8

3.4

e6/l

67.8

69.6

0.02

637

3765

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

140

4.94

31.42

1.6

1.5

umol/l

3.4

5.1

3.39

125

(3030467) Casts [#/volume] in Urine by Automated count

717

4599

1.75

30.22

4.4

3.4

e6/l

0.3

0.45

600

3413

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

131

4.97

29.89

1.8

1.2

nmol/l

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1232

9161

1.68

29.79

7.5

5.6

mmol/l

6.4

0.13

1175

8454

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

779

5136

1.72

29.61

1.5

1.6

u/ml

1.1

2.5

4.06

184

1144

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

197

4.12

29.33

3.7

3.8

u/ml

86.7

1477.8

0.59

187

(36304419) Bacteria [Presence] in Urine

709

4583

1.73

28.77

4.5

3.3

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1464

11514

1.69

27.47

5.4

4.0

mm/h

10.9

9.9

1.99

1356

10695

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

147

4.49

26.93

1.8

1.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

666

4297

1.71

26.84

3.5

2.6

u/l

56.5

56.2

0.04

602

3978

(3013512) EKG study

560

3447

1.76

26.68

3.7

3.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

709

4669

1.69

26.38

1.8

1.5

g/l

1.9

2.0

0.14

366

2641

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

393

2196

1.88

25.64

4.4

2.8

mmol/l

2.4

0.87

354

1895

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1549

12471

1.69

25.46

5.8

4.7

mmol/mol

38.0

38.5

1.27

1444

11615

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

853

5956

1.62

24.86

4.3

3.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

302

3.22

24.30

1.8

1.9

—

(3002385) Erythrocyte distribution width [Ratio]

1803

15225

1.84

24.10

23.5

14.9

13.6

13.4

5.59

1776

14930

(3003338) MCHC [Mass/volume]

1404

15620

0.61

23.99

22.5

15.2

g/l

333.5

333.7

0.49

1395

15486

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

503

3091

1.74

23.72

4.2

3.8

ng/l

923.7

1184.5

1.32

423

2603

(3022145) Colonoscopy Study observation

282

1449

2.00

23.44

1.4

—

(40758558) Short blood count panel - Blood

695

4691

1.63

22.78

10.2

7.6

—

(3018095) Leukocytes [#/volume] in Urine

845

5994

1.58

22.42

5.4

4.0

e6/l

77.3

84.3

0.11

653

4017

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

264

3.26

22.14

1.8

1.9

—

(3035350) Ketones [Presence] in Urine by Test strip

1063

8008

1.55

21.23

4.3

3.4

estimate

0.0

0.00

441

1479

(3021601) Nitrite [Presence] in Urine by Test strip

1064

8018

1.54

21.22

5.5

4.7

estimate

0.0

0.50

443

1540

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

6.12

21.17

1.5

1.7

—

(3009261) Glucose [Presence] in Urine by Test strip

1068

8090

1.53

20.55

4.3

3.4

estimate

0.0

0.50

437

1490

(3023368) Bacteria identified in Blood by Culture

547

3554

1.64

20.51

6.2

4.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

6.05

20.39

1.5

1.7

—

(3021901) Oxygen saturation in Capillary blood

300

3.00

20.16

8.5

3.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

152

3.88

20.02

1.4

1.3

pmol/l

476.5

343.0

0.31

118

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

7.96

19.56

2.4

2.0

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

190

902

2.13

19.45

18.6

14.4

mg/l

1.4

1.1

4.04

179

871

(3027945) Reticulocytes/100 erythrocytes in Blood

323

1840

1.81

19.41

5.5

4.3

1.6

0.06

288

1689

(3023520) Reticulocytes [#/volume] in Blood

251

1319

1.94

19.41

4.1

3.6

e9/l

67.4

67.5

0.02

177

900

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

648

4437

1.58

19.36

4.1

3.2

ng/l

34.8

49.5

0.59

432

2641

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

4.54

18.54

1.6

1.7

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

301

2.89

18.28

1.7

1.4

nmol/l

0.3

0.4

0.66

242

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

5.23

18.02

1.5

1.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

195

967

2.03

17.75

2.0

1.7

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1054

8144

1.48

17.26

4.0

2.9

ug/l

98.4

85.4

1.30

963

7611

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

104

402

2.56

17.09

12.0

7.5

iu/ml

3557.3

279.3

0.60

(1761868) Lipid panel - Serum or Plasma

706

5048

1.51

16.85

3.2

2.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

344

2.67

16.69

2.1

1.9

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

112

456

2.44

16.50

2.3

1.9

—

(3025941) Bacteria identified in Stool by Culture

188

945

2.00

16.46

1.3

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

112

458

2.43

16.34

2.3

1.9

—

(3005719) IgG [Mass/volume] in Serum or Plasma

267

1512

1.80

16.22

4.7

3.0

g/l

9.4

9.9

1.51

244

1405

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

186

3.27

16.13

1.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

5.76

15.67

2.3

1.8

—

(3042631) Mycobacterium sp identified in Specimen

143

3.56

15.47

2.7

3.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

526

3638

1.52

14.29

1.8

1.7

mmol/l

1.5

1.3

2.77

368

3164

(3048689) Calprotectin [Mass/mass] in Stool

411

2694

1.58

14.23

2.8

ug/g

101.8

111.3

0.37

308

2149

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

193

1033

1.88

14.02

3.6

4.2

ug/l

9.9

22.8

0.82

145

826

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

240

2.82

13.96

4.3

3.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

327

2048

1.63

13.64

2.5

1.7

nmol/l

1573.0

1158.0

9.81

238

1538

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

271

2.68

13.59

1.7

1.5

—

(40768797) Stomach Pathology biopsy report

295

1811

1.66

13.30

1.6

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

341

2.46

12.97

12.4

7.3

u/ml

379.4

1065.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

211

1189

1.78

12.96

2.4

1.8

g/l

1.1

1.2

0.41

198

1111

(3006184) Hemoglobin [Mass/volume] in Capillary blood

355

2.41

12.80

2.8

2.3

g/l

131.8

132.0

0.03

289

(3031040) Bacteria [#/volume] in Urine by Automated count

1304

10811

1.40

12.76

5.7

4.0

e6/l

1165.1

1747.6

0.23

129

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

252

2.69

12.75

4.1

3.0

8.5

10.0

0.65

206

(3013336) Amino acids [Identifier] in Serum or Plasma

4.14

12.60

2.5

2.4

—

(3026008) Bacteria identified in Urine by Culture

622

4543

1.45

12.59

3.1

2.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

426

2.27

12.50

2.0

ug/l

1.9

2.3

0.17

374

(3023103) Potassium [Moles/volume] in Serum or Plasma

1834

16241

1.57

12.44

22.4

13.3

mmol/l

3.9

0.03

1787

15715

(3026493) Urate [Moles/volume] in Serum or Plasma

451

3100

1.50

12.40

3.3

3.1

umol/l

1743.9

5379.2

2.33

405

2745

(3019550) Sodium [Moles/volume] in Serum or Plasma

1831

16216

1.57

12.33

22.1

13.3

mmol/l

139.4

139.5

1.07

1790

15738

(3011412) CD3 cells [#/volume] in Blood

280

2.56

12.25

4.3

2.9

e9/l

1.5

1.4

0.28

174

(40761539) Cells [Type] in Urine sediment by Light microscopy

6.17

12.19

1.2

1.4

—

(3004451) EKG impression Narrative

4.86

11.75

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

117

3.42

11.60

1.3

1.1

—

(3008295) Osmolality of Serum or Plasma

201

2.77

11.30

2.4

1.6

mosm/kgh2o

283.6

289.2

1.16

152

(3044889) 12 lead EKG panel

1136

9330

1.36

11.00

4.5

3.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1343

11331

1.37

10.91

5.5

4.1

—

(40768441) Liver Pathology biopsy report

138

3.11

10.73

1.5

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

175

2.85

10.64

1.8

1.6

—

(40761511) CBC panel - Blood by Automated count

1944

17591

1.63

10.42

18.3

10.4

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

4.12

10.38

9.4

8.5

mg/l

2.1

2.5

0.49

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

246

2.51

10.24

1.7

1.4

—

(3003181) Sodium [Moles/volume] in Urine

264

2.45

10.20

4.2

2.4

mmol/l

73.5

72.2

0.08

227

(3000012) Reticulocyte production index

4.16

10.15

1.1

1.9

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.41

10.11

6.1

6.7

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

4.41

10.11

6.2

7.0

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

241

1505

1.61

10.06

5.1

5.0

u/l

248.2

263.6

0.57

224

1437

(36660697) Celiac disease serology panel - Serum

302

1995

1.53

9.86

1.3

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

671

5142

1.37

9.80

4.4

3.7

u/l

30.8

32.1

0.65

627

4909

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

212

2.58

9.71

1.7

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

297

1969

1.52

9.52

14.0

7.6

mmol/l

1.2

1.1

0.20

212

1438

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

333

2264

1.49

9.46

2.2

1.9

—

(3033658) Prothrombin time (PT) actual/Normal

552

4126

1.39

9.32

7.9

5.4

89.5

0.01

540

4038

(3009343) pH of Capillary blood

299

1998

1.51

9.22

14.1

7.6

7.4

0.15

115

(3002256) Pathology report gross observation

266

1735

1.54

9.18

1.2

—

(3019977) pH of Arterial blood

4.16

9.04

2.0

3.4

7.4

0.26

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1892

17115

1.51

8.97

14.5

9.2

u/l

26.3

25.7

0.51

1831

16523

(40760888) Immunoglobulin light chains.free panel - Serum

192

2.59

8.97

3.0

4.2

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.52

8.78

9.7

7.8

—

(3016750) Collection duration of Urine

3.69

8.67

2.6

2.5

min

530.8

510.2

0.43

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.69

8.67

13.0

7.7

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

4.40

8.11

1.7

2.1

mg/l

1.8

2.8

0.34

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

4.40

8.11

1.7

2.1

mg/l

1.0

1.3

0.28

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

4.40

8.11

1.7

2.1

mg/l

1.1

1.2

0.07

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

4.40

8.11

1.7

2.1

mg/l

1.6

6.5

2.64

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

4.40

8.11

1.7

2.1

mg/l

3.5

3.9

0.10

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.40

8.11

1.7

2.1

mg/l

0.9

0.7

0.17

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

4.40

8.11

1.7

2.1

mg/l

0.9

1.2

0.38

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

4.40

8.11

1.7

2.1

mg/l

1.2

3.0

1.08

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

4.40

8.11

1.7

2.1

mg/l

0.9

1.6

0.66

(3042936) Bacteria identified in Isolate by Culture

296

2034

1.46

7.91

2.3

1.9

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

502

3788

1.36

7.81

2.5

2.3

u/l

146.4

256.2

3.84

460

3596

(3017569) Oxygen content in Arterial blood

3.95

7.78

1.8

3.3

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3.78

7.66

1.3

1.9

nmol/l

20.3

19.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1213

10353

1.29

7.61

5.1

3.3

u/l

49.5

38.5

2.62

1130

9800

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

3.07

7.54

2.1

1.3

—

(3037522) Nuclear Ab [Titer] in Serum

319

2245

1.43

7.49

1.7

1.4

titre

478.3

523.4

0.15

417

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

125

2.80

7.44

1.2

1.1

u/l

83.0

149.9

0.76

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

266

2.20

7.42

3.5

3.9

mg/l

34.1

40.9

0.24

223

(3034860) Kappa light chains.free [Mass/volume] in Serum

266

2.20

7.42

3.6

3.9

mg/l

52.1

72.5

0.39

223

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

286

2.15

7.36

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

412

1.95

7.29

2.0

1.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

401

2957

1.37

7.15

1.6

1.4

nmol/l

21.8

20.4

0.97

339

2534

(3020630) Protein [Mass/volume] in Serum or Plasma

151

921

1.62

6.95

2.6

3.1

g/l

66.1

66.2

0.04

140

850

(3005322) IgE [Units/volume] in Serum or Plasma

227

1519

1.49

6.92

1.6

1.3

u/ml

330.2

257.1

0.56

207

1421

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

143

862

1.64

6.90

6.1

7.1

92.7

91.4

0.28

136

830

(3004775) Volume in Urine collected for unspecified duration

3.09

6.90

2.5

660.2

611.5

0.23

(3027135) IgG subclass 1 [Mass/volume] in Serum

212

2.30

6.89

1.3

g/l

7.1

6.4

0.70

170

(3028192) IgG subclass 2 [Mass/volume] in Serum

212

2.30

6.89

1.3

g/l

2.4

0.03

169

(3024139) IgG subclass 3 [Mass/volume] in Serum

212

2.30

6.89

1.3

g/l

0.4

0.00

168

(4062490)

213

2.29

6.82

1.4

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

266

1844

1.44

6.76

6.7

4.4

umol/l

6.0

7.0

0.69

206

1553

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

254

1751

1.45

6.65

12.5

7.7

mmol/l

23.4

23.8

1.55

249

1663

(3007853) Bacteria identified in Skin by Aerobe culture

285

2008

1.42

6.63

2.1

1.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

155

963

1.59

6.63

5.0

3.8

ng/l

219.5

181.2

0.32

144

868

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

422

1.88

6.50

7.1

10.5

u/ml

0.3

0.11

240

(44790048)

301

2.04

6.48

2.2

2.0

—

(44806118)

301

2.04

6.48

2.2

2.0

—

(3036489) Thrombin time

139

848

1.62

6.41

5.0

22.9

22.4

0.32

126

785

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.01

6.40

5.0

5.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

437

3332

1.33

6.19

2.9

2.6

mg/l

2.1

1.2

0.94

316

2440

(44790049)

301

2.01

6.13

2.2

2.0

—

(44790047)

301

2.01

6.13

2.2

2.0

—

(3020650) Glucose [Presence] in Urine

4.18

6.13

1.1

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

613

0.37

5.98

1.2

1.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

3.61

5.98

2.0

1.4

2.7

5.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

408

1.85

5.90

1.7

1.3

ug/l

9.2

4.0

1.10

387

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

2.80

5.87

2.1

1.5

28.7

38.7

0.72

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1486

0.60

5.72

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

558

4445

1.28

5.65

3.9

3.7

mmol/l

6.9

7.9

5.11

464

3861

(40768446) Kidney Pathology biopsy report

100

2.72

5.56

3.7

1.8

—

(3007461) Platelets [#/volume] in Blood

2063

19282

1.65

5.52

28.1

17.3

e9/l

264.3

259.8

2.02

2018

18656

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

189

2.21

5.51

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1502

13398

1.26

5.51

19.5

9.9

ml/min/173m2

90.3

90.8

0.35

1304

10358

(3000060) B lymphocytes [#/volume] in Blood

208

2.15

5.51

5.1

3.3

e6/l

303.6

392.5

0.58

128

(3000991) Gas panel - Venous blood

278

2013

1.38

5.49

14.0

9.8

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

4.03

5.49

3.9

3.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1482

0.61

5.49

6.4

5.7

—

(3024731) MCV [Entitic volume]

2063

19295

1.63

5.33

28.0

17.2

88.9

89.0

0.61

2043

19023

(3035941) MCH [Entitic mass]

2063

19296

1.63

5.31

28.0

17.2

29.6

29.8

3.37

2043

19023

(3026361) Erythrocytes [#/volume] in Blood

2063

19299

1.63

5.27

28.0

17.3

e12/l

4.5

3.84

2016

18615

(3022493) Free Hemoglobin [Mass/volume] in Plasma

109

2.58

5.24

2.6

6.2

mg/l

76.4

89.0

0.42

100

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

333

2502

1.33

5.17

1.3

1.2

iu/ml

33.6

26.0

0.33

712

(3010813) Leukocytes [#/volume] in Blood

2063

19306

1.62

5.17

28.2

17.3

e9/l

6.9

6.8

0.28

2017

18626

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

139

2.37

5.16

2.0

1.6

69.0

54.9

1.24

(3042733) HLA Ab [Presence] in Serum

2.89

5.15

4.0

3.7

—

(3000963) Hemoglobin [Mass/volume] in Blood

2063

19309

1.62

5.12

28.4

17.5

g/l

132.3

134.5

9.93

2041

19039

(21494755) Public health laboratory ask at order entry panel

120

1729

0.65

5.07

1.1

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

488

1.70

5.01

2.7

2.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

167

2.21

4.91

1.8

1.4

u/ml

0.8

0.02

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1850

17006

1.32

4.90

19.9

11.7

mg/l

21.0

22.6

1.23

1496

12778

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.52

4.89

4.0

6.0

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

3.36

4.85

2.6

3.3

mg/l

8.7

26.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

449

1.72

4.84

1.8

1.5

titre

85.5

71.0

0.38

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.23

4.83

1.6

1.5

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

253

1.96

4.81

5.0

3.0

e6/l

682.6

564.5

0.71

188

(40768804) Tissue Pathology biopsy report

668

5520

1.24

4.81

2.1

1.9

—

(3000494) Fungus identified in Specimen by Culture

245

1778

1.37

4.78

2.0

1.5

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

4.29

4.76

1.0

1.4

—

(40768795) Lymph node Pathology biopsy report

127

2.37

4.71

1.3

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

557

1.63

4.70

2.6

1.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

224

1608

1.38

4.67

2.2

1.9

—

(3002032) Base excess in Venous blood by calculation

297

2228

1.33

4.65

12.6

7.4

mmol/l

1.0

1.5

1.38

221

1771

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

536

1.64

4.65

2.7

1.9

u/ml

79.3

97.1

0.52

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

250

1.95

4.63

5.0

3.0

e9/l

0.2

0.42

188

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

196

1381

1.40

4.57

1.3

1.2

iu/ml

119.3

160.1

0.66

497

(3026389) Candida sp identified in Specimen by Organism specific culture

220

1.99

4.45

1.7

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

107

2.45

4.42

1.6

—

(3045142) Bone marrow Pathology biopsy report

188

2.07

4.40

1.6

1.5

—

(3023419) Bacteria identified in Sputum by Culture

156

2.18

4.40

7.3

4.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

103

644

1.57

4.38

2.1

2.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

107

675

1.55

4.37

2.4

1.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

448

1.68

4.37

4.3

3.3

umol/l

37.2

33.5

0.85

392

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

2.52

4.37

1.2

1.1

ratio

1.1

0.25

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.56

4.36

1.8

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

229

1.95

4.33

1.9

1.7

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.22

4.31

1.4

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

223

1.96

4.30

1.2

1.4

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

4.60

4.29

6.2

6.5

ug/min

27.8

19.9

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

308

2349

1.30

4.29

1.3

1.2

u/ml

6.0

10.7

1.09

118

860

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

210

1.99

4.28

1.2

1.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1047

0.59

4.25

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

365

1.74

4.20

2.7

2.5

—

(3021788) Differential panel - Synovial fluid

226

1.93

4.15

1.7

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

104

662

1.54

4.10

2.5

1.7

u/ml

268.5

188.9

1.75

335

(3042111) Morphology [Interpretation] in Bone marrow Narrative

188

2.01

4.04

2.0

2.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

125

2.25

3.97

1.2

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

113

2.31

3.95

1.2

1.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.49

3.95

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

529

1.59

3.95

2.5

2.0

g/l

1.2

1.4

0.89

470

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

606

1.55

3.94

2.2

1.7

g/l

0.2

0.25

578

(3012516) Albumin [Mass/volume] in Urine

406

3238

1.25

3.94

3.4

mg/l

121.7

251.7

0.97

253

2140

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

210

1.94

3.93

4.2

2.6

e6/l

1006.3

760.8

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

168

1186

1.39

3.90

1.2

1.1

—

44.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

324

1.74

3.85

1.4

1.7

g/l

0.8

0.16

267

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

2.51

3.82

1.3

1.5

u/l

4.0

6.7

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

621

1.53

3.75

2.2

1.7

g/l

1.2

0.08

590

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

7.02

3.75

1.6

1.8

ng/l

104.1

94.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

2.48

3.74

4.3

3.0

u/ml

823.8

1021.7

0.44

(3045462) Protein/Creatinine [Ratio] in Urine

155

2.06

3.68

5.0

7.6

g/mol

48.4

379.3

0.56

144

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.63

3.63

2.9

1.8

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

6.43

3.56

5.1

1.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

253

1.80

3.55

1.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

214

1598

1.32

3.49

2.1

1.8

—

(3006653) Thiamine [Moles/volume] in Blood

2.64

3.48

1.1

1.3

nmol/l

128.4

142.5

0.69

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

411

1.61

3.40

2.0

3.6

u/ml

34.0

3491.5

0.79

347

(3018677) aPTT in Platelet poor plasma by Coagulation assay

313

2464

1.26

3.39

4.6

3.9

30.5

30.3

0.38

300

2409

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

389

1.63

3.38

1.8

2.3

—

(4034850)

413

0.44

3.37

9.3

9.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

273

1.74

3.32

2.6

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

6.75

3.27

3.9

5.8

—

(3034770) Mitochondria Ab [Titer] in Serum

447

1.57

3.24

1.6

1.4

titre

—

1276.3

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

2.45

3.19

1.4

1.7

—

875521.4

—

(3037121) Protein [Mass/volume] in Urine

106

717

1.44

3.18

5.9

5.7

g/l

0.2

0.3

2.35

442

(3000492) Spirometry study

196

1468

1.31

3.14

1.6

1.4

—

(3022313) Gas panel - Capillary blood

220

1675

1.29

3.13

16.1

7.7

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

451

1.55

3.12

1.3

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

451

1.55

3.12

1.3

1.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.82

3.07

1.9

1.7

—

(40761535) Cells panel - Urine sediment

1050

0.67

2.99

3.9

3.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

2.42

2.96

3.9

7.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

240

1.74

2.93

1.9

1.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

162

1195

1.33

2.91

2.1

1.5

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

4.14

2.88

1.3

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

431

1.53

2.83

2.5

3.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

6.43

2.79

3.5

2.0

—

(3019150) Specific gravity of Urine by Refractometry

312

3555

0.82

2.74

4.2

3.5

kg/l

1.0

0.40

570

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.03

2.74

1.5

2.2

—

(40768443) Skin Pathology biopsy report

531

1.47

2.69

1.3

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.20

2.69

1.4

2.5

umol/l

228.4

145.9

—

(3022725) Serotonin [Moles/volume] in Serum

8.03

2.68

2.0

1.2

nmol/l

546.0

1110.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

821

0.65

2.68

1.5

1.9

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

186

1416

1.29

2.67

2.7

2.3

u/l

32.4

37.3

0.43

170

1192

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

2.26

2.58

1.4

1.1

u/l

270.1

97.2

0.39

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

199

1.75

2.57

2.0

1.9

—

(40757373) Influenza virus identified in Isolate

3.62

2.56

1.6

1.5

—

(3029075) Extractable nuclear Ab panel - Serum

2.15

2.56

1.4

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

130

1.94

2.53

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.87

2.51

1.2

1.1

—

(4281824)

117

1.98

2.51

1.1

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.50

1.2

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

2.34

2.49

2.6

3.8

ug/l

92.5

153.4

0.78

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

131

1.92

2.48

1.2

81.5

77.6

0.19

131

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

131

1.92

2.48

1.3

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.86

2.47

1.9

1.3

—

(3028433) Virus identified in Specimen by Culture

2.20

2.45

1.3

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

195

1.74

2.45

1.4

1.5

—

(3037756) Immunofixation for Serum or Plasma

188

1.75

2.44

1.6

—

(3022217) INR in Platelet poor plasma by Coagulation assay

100

1293

0.73

2.43

22.8

21.4

inr

1.2

1.3

0.26

196

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

4.22

2.39

2.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

161

1.80

2.38

1.2

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

2.08

2.37

1.7

1.4

—

66.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

100

2.03

2.35

4.2

2.1

u/field

1.6

2.2

0.46

(3027923) C peptide [Moles/volume] in Serum or Plasma

2.27

2.35

1.3

1.8

nmol/l

1.5

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

405

3396

1.18

2.33

5.3

4.2

mg/mmol

14.7

14.1

0.03

254

2219

(3019174) dRVVT (LA screen)

3.97

2.27

1.0

1.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

597

5182

1.15

2.19

1.9

1.8

pmol/l

95.3

96.0

0.13

331

2714

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

691

0.66

2.16

15.5

7.5

0.6

0.7

0.46

672

(3003327) Ova and parasites identified in Stool by Light microscopy

107

780

1.34

2.15

1.8

—

(3012441) Differential panel - Pleural fluid

1.99

2.15

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

1788

16694

1.18

2.15

18.8

13.6

39.2

39.7

2.50

1315

13461

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

5.35

2.15

6.4

2.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.35

2.15

1.0

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

160

1.75

2.13

1.9

1.6

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

318

1.52

2.12

1.3

1.2

—

5.1

—

(3020393) Adenovirus Ag [Presence] in Stool

154

1.76

2.08

3.2

1.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

512

1.40

2.06

4.3

3.6

umol/l

9.8

8.2

0.40

412

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.08

2.05

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

546

1.39

2.04

1.6

1.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.53

2.02

1.3

1.2

—

(3045424) Erythrocytes [Presence] in Urine

237

1.59

2.02

1.3

1.4

—

(3009871) Measles virus Ab [Titer] in Serum

2.41

2.02

2.1

1.9

—

(3035880) pH of Pleural fluid

2.41

2.02

1.3

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

1.97

2.00

1.3

2.2

—

2.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

172

1354

1.24

1.93

2.6

2.3

u/l

9397.3

7287.5

0.20

525

(3039162) Centromere protein B Ab [Units/volume] in Serum

210

1.61

1.92

1.3

—

45.7

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

364

3966

0.86

1.90

3.6

3.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.54

1.86

2.4

1.6

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.61

1.86

1.2

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.41

1.86

3.5

1.8

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.15

1.84

1.4

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

3.07

1.80

1.3

1.9

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

169

1.66

1.80

2.6

4.0

u/ml

74.0

83.4

0.08

(3030313) Adrenal Ab [Titer] in Serum

2.75

1.77

1.8

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1218

0.77

1.76

1.5

1.3

—

(3028717) Thiamine [Mass/volume] in Blood

4.01

1.76

1.0

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.04

1.75

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

110

833

1.28

1.73

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

188

2148

0.83

1.73

3.7

4.1

22.9

21.1

1.00

977

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

2.23

1.72

1.5

2.1

u/l

200.3

205.2

0.10

(3044242) Glucose [Moles/volume] in Arterial blood

2.08

1.71

2.2

2.8

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

325

2748

1.16

1.70

4.0

3.1

e6/l

4.0

2.7

0.81

192

1498

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

135

1.72

1.70

1.3

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

433

1.39

1.69

2.0

1.9

iu/l

2.3

4.6

4.55

151

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

459

1.37

1.66

2.4

2.8

mmol/l

3.6

3.5

0.55

435

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.71

1.65

5.6

4.9

mmol/l

5.3

7.5

—

(4306422)

258

1.50

1.65

1.2

—

(3003694) ABO and Rh group [Type] in Blood

540

5676

0.89

1.65

1.8

1.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

370

1.41

1.64

1.3

1.2

iu/ml

12.6

183.2

4.95

117

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.81

1.64

6.6

12.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

235

1.52

1.64

4.3

4.1

—

(44813793)

189

1.59

1.63

1.0

1.1

—

(3001556) Androgen free Index in Serum or Plasma

3.04

1.59

1.3

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

3.04

1.59

1.3

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.04

1.59

1.2

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

237

1.51

1.59

1.1

g/l

1.4

1.5

0.08

218

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

455

1.36

1.58

2.5

2.6

ug/l

227.1

447.0

1.11

427

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

128

1505

0.81

1.58

3.6

3.8

32.9

32.3

0.23

1040

(3014111) Lactate [Moles/volume] in Serum or Plasma

177

1431

1.21

1.58

10.4

10.3

mmol/l

1.6

1.3

1.45

169

1339

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.21

1.56

1.2

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.44

1.55

1.2

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

255

1.48

1.53

1.4

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

295

1.44

1.52

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

219

1812

1.18

1.52

1.8

1.9

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

2.89

1.51

4.3

4.4

mg/l

3.1

3.9

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

377

1.39

1.50

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

247

0.54

1.50

1.8

1.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

460

1.35

1.49

2.6

2.9

e6/l

10.6

12.5

0.13

339

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

461

1.35

1.47

2.7

2.9

e6/l

328.6

8604.1

0.49

351

(3049233) Organic acids panel - Urine

2.07

1.47

1.5

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.35

1.44

1.2

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

188

1.54

1.44

1.6

1.2

—

(40768806) Pleura Pathology biopsy report

1.80

1.44

1.2

1.6

—

(21494434) Karyotype in Bone marrow

135

1.65

1.43

1.5

1.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

256

2159

1.16

1.41

1.8

1.7

1.5

1.4

1.03

219

1929

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

128

1.66

1.41

2.1

3.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

128

1.66

1.41

2.1

3.5

—

(40768793) Breast Pathology biopsy report

308

1.41

1.5

1.2

—

(3032641) Amino acids panel - Urine

2.28

1.41

1.4

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

295

2515

1.15

1.41

1.8

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1020

0.78

1.40

1.7

1.5

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.96

1.40

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

134

0.43

1.39

1.0

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

2.41

1.38

1.7

2.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.63

1.37

1.3

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

286

1.42

1.36

1.3

u/ml

1.9

4.3

1.37

107

(3016650) Hepatitis A virus Ab [Presence] in Serum

295

1.41

1.34

1.0

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.14

1.34

1.2

1.6

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.83

1.30

1.4

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

241

1.44

1.29

2.4

3.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

922

0.79

1.28

1.6

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

921

0.79

1.27

1.6

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

920

0.79

1.26

1.6

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1481

13819

1.10

1.25

4.5

3.7

mmol/l

5.7

0.25

1338

12642

(40759836) Histone Ab [Presence] in Serum by Immunoblot

156

1.55

1.25

1.3

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

156

1.55

1.25

1.3

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

156

1.55

1.25

1.3

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

156

1.55

1.25

1.3

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

156

1.55

1.25

1.3

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

918

0.79

1.24

1.6

1.5

—

(3017732) Neutrophils [#/volume] in Blood

134

1084

1.20

1.24

2.4

e9/l

4.1

4.2

0.16

110

907

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

825

7505

1.09

1.23

5.1

4.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

178

1478

1.17

1.22

1.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

157

1.54

1.22

1.3

1.2

—

(3035285) Chloride [Moles/volume] in Venous blood

137

0.49

1.21

1.6

2.7

mmol/l

106.6

105.5

—

137

(3028300) Cannabinoids [Presence] in Urine

129

1464

0.84

1.17

2.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1517

14190

1.10

1.16

3.7

—

(3044009) aPTT.lupus sensitive (LA screen)

2.53

1.16

1.0

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.53

1.16

1.4

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.78

1.16

1.1

—

(3027008) Opiates [Presence] in Urine

129

1462

0.84

1.15

2.0

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

1.15

0.0

1.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

611

5498

1.10

1.15

1.8

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

272

1.39

1.14

1.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

611

1.25

1.13

1.1

u/ml

0.9

9.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

129

1.57

1.13

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

128

1449

0.84

1.13

2.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

168

1.49

1.13

1.1

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

1.66

1.12

3.4

3.9

0.2

2.3

—

(3027944) Amphetamines [Presence] in Urine

127

1437

0.84

1.12

2.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.41

1.10

3.4

1.7

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

754

0.78

1.10

1.7

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

131

0.51

1.10

1.6

2.7

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

679

0.77

1.10

1.7

1.6

mg/l

3.3

4.3

0.41

463

(3019225) pH of Specimen

140

1156

1.18

1.06

4.7

3.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

449

3998

1.10

1.05

1.8

1.7

—

(3019060) Gas panel - Arterial blood

679

1.23

1.05

3.0

5.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

109

1.59

1.04

1.3

1.2

—

(3049717) Cytology report of Urine Cyto stain

370

1.31

1.03

2.9

2.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

278

1.36

1.03

3.6

2.6

ug/min

69.9

99.0

0.27

181

(3051651) Icteric interference index of Serum or Plasma

157

1.48

1.00

3.3

4.8

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.62

1.00

1.0

1.1

miu/ml

1217.9

1486.9

0.44

(3042517) Benzodiazepines panel - Urine

1.98

0.99

2.3

2.4

—

(3040893) Potassium [Moles/volume] in Capillary blood

2.19

0.98

8.0

2.9

mmol/l

4.7

4.6

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.64

0.98

1.0

1.2

98.9

82.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

111

1.56

0.98

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

127

1.52

0.96

1.7

1.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

695

1.21

0.96

1.3

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

282

1.34

0.95

1.3

u/ml

2.2

4.3

2.38

131

(3047352) Trisomy 18 risk [Likelihood] in Fetus

739

0.80

0.95

1.6

1.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

333

1.31

0.94

1.9

2.1

mg/l

8.4

11.1

0.99

309

(3041354) Potassium [Moles/volume] in Venous blood

138

0.56

0.93

1.5

2.7

mmol/l

4.1

4.0

—

138

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

1.73

0.93

1.1

1.4

—

264.3

—

(3044640) Blood type and Crossmatch panel - Blood

560

5065

1.09

0.93

3.5

2.5

—

(3005033) Fetal Nuchal fold Thickness US

736

0.80

0.93

1.6

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.87

0.92

2.1

2.3

—

(40758292) HTLV I+II Ab panel - Serum

1.87

0.92

1.0

1.3

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.14

0.91

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.14

0.91

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.14

0.91

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.14

0.91

1.2

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

233

2478

0.89

0.90

2.0

2.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.63

0.89

1.1

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

356

3702

0.91

0.89

2.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

244

1.35

0.88

1.8

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.59

0.88

1.1

96.3

89.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

278

1.32

0.88

1.1

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.88

0.87

1.5

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

475

0.77

0.87

1.2

1.9

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

194

1669

1.13

0.87

10.1

8.2

mmol/l

105.1

104.8

0.38

189

1634

(3013139) Helicobacter pylori Ag [Presence] in Stool

118

980

1.17

0.87

1.1

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

107

1.53

0.86

6.5

4.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

416

1.26

0.85

1.2

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

335

2976

1.10

0.84

1.5

—

(3016879) Cocaine [Presence] in Urine

123

1350

0.87

0.79

2.0

2.1

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.79

0.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.79

0.0

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

144

0.60

0.79

1.1

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

191

0.65

0.77

1.1

1.4

—

183.3

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.66

0.76

1.1

1.4

—

47.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

388

3988

0.92

0.76

3.5

2.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

135

1.43

0.75

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

155

0.62

0.75

1.8

1.6

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1452

14266

0.94

0.75

4.4

4.0

mmol/l

2.7

3.32

1310

13230

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

373

1.24

0.73

1.1

u/ml

0.7

4.0

2.47

152

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

102

852

1.16

0.73

1.7

1.8

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

287

1.28

0.73

1.1

iu/ml

3.4

7.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

104

1146

0.87

0.73

2.1

2.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

137

1.41

0.71

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

632

1.18

0.69

2.5

2.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

316

2831

1.09

0.68

4.1

3.0

e6/l

0.9

1.1

0.43

185

1575

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.56

0.68

2.0

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.56

0.68

2.0

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.56

0.68

2.0

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

1.85

0.68

1.8

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.53

0.68

1.2

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

924

0.86

0.67

2.0

2.3

ug/l

5.3

7.1

0.88

812

(3045683) HLA typing for celiac disease panel - Blood or Tissue

147

1.38

0.67

1.0

—

(3017509) Phencyclidine [Presence] in Urine

1.78

0.66

2.8

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

198

1.32

0.65

3.5

4.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

107

1.44

0.65

1.1

1.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

174

1.33

0.63

1.2

1.1

—

(3022621) pH of Urine by Test strip

1008

0.87

0.62

3.2

2.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

295

1.24

0.61

1.2

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

209

1.29

0.61

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1430

14016

0.95

0.61

4.3

3.6

mmol/l

1.4

1.5

1.98

1293

13050

(3003396) Base excess in Arterial blood by calculation

153

1333

1.11

0.60

7.9

9.7

mmol/l

0.6

0.8

0.22

122

1046

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1370

13443

0.95

0.60

3.9

3.4

mmol/l

1.3

1.2

3.58

1232

12497

(4268621)

201

1.30

0.60

2.4

2.5

—

(3041806) Other cells [#/volume] in Blood by Manual count

190

0.71

0.59

1.4

1.6

—

(3020891) Body temperature

482

1.18

0.58

6.5

5.2

—

(3000285) Sodium [Moles/volume] in Blood

0.00

0.58

0.0

1.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.51

0.58

3.3

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.51

0.58

3.3

1.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

581

1.16

0.58

1.5

1.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

397

4030

0.94

0.57

2.4

—

(3033799) Differential panel - Peritoneal fluid

1.70

0.57

2.7

1.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

237

2452

0.92

0.57

3.2

3.7

ng/l

370.3

587.0

0.86

150

1688

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.48

0.57

1.6

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.48

0.57

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.48

0.57

1.6

1.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.48

0.57

7.4

6.7

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

807

0.87

0.57

12.5

11.6

1.0

1.3

2.65

801

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

169

1.31

0.56

1.1

1.2

mg/l

41.1

34.2

0.33

132

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

113

976

1.12

0.54

1.7

1.9

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

120

1.37

0.54

1.1

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

894

0.88

0.53

1.5

1.6

—

(3027801) Oxygen [Partial pressure] in Arterial blood

152

1336

1.10

0.53

8.0

9.6

kpa

13.2

13.3

0.12

146

1285

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1446

14143

0.95

0.53

4.3

3.7

mmol/l

4.5

4.6

3.81

1310

13246

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

152

1337

1.10

0.52

8.0

9.6

kpa

5.3

5.2

0.64

146

1284

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.52

0.52

1.7

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

146

1.32

0.52

1.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

321

3269

0.93

0.52

1.9

1.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

553

1.15

0.50

1.7

1.9

u/l

40.7

38.9

0.31

506

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

297

2693

1.07

0.50

4.6

ug/l

1.6

2.7

2.11

256

2403

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

199

1.26

0.49

1.2

1.1

92.0

93.2

0.11

188

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.41

0.49

1.5

1.4

g/l

1.0

0.08

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.41

0.49

1.6

1.7

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.50

0.47

4.4

2.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.50

0.47

1.0

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

503

1.15

0.46

1.1

u/ml

8.2

9.0

0.10

273

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

361

0.82

0.46

2.5

2.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

266

0.79

0.46

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

158

1.28

0.46

1.0

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

107

1.35

0.46

1.0

1.1

—

(4146454)

116

0.66

0.45

2.1

2.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.46

0.45

1.5

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

286

0.81

0.45

1.7

1.6

e6/l

9510.0

13968.2

0.64

210

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

286

0.81

0.45

1.5

1.6

mmol/l

6.8

7.3

0.65

178

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

202

1.24

0.45

1.1

1.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

824

1.11

0.45

1.1

1.2

u/ml

4.7

6.4

0.65

572

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.38

0.44

1.0

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

197

2025

0.93

0.43

1.8

2.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

203

1.23

0.43

2.6

1.8

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.43

0.42

3.4

1.8

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.44

0.42

1.5

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

252

0.80

0.42

1.1

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

826

0.89

0.42

1.3

miu/ml

225.5

241.8

0.15

410

(21494890) Protein electrophoresis panel - 24 hour Urine

0.63

0.42

3.3

2.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.63

0.42

1.0

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

178

1.25

0.41

1.7

1.6

u/ml

16.5

9.6

—

(3004616) Nuclear Ab [Presence] in Serum

152

1.27

0.41

1.2

1.3

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

26.5

—

(3051593) INR in Capillary blood by Coagulation assay

1.50

0.41

46.8

10.6

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

804

0.89

0.41

12.1

11.7

0.6

0.7

0.61

799

(42529406) Shigella sp [Presence] in Stool by Culture

540

0.87

0.40

1.4

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

0.00

0.40

0.0

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

112

1174

0.91

0.40

1.5

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.33

0.40

1.4

1.2

—

(40768800) Prostate Pathology biopsy report

153

1.26

0.40

1.3

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

312

1.17

0.40

1.4

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.42

0.40

4.5

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.42

0.40

4.5

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.42

0.40

4.5

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.42

0.40

4.4

1.8

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.42

0.39

1.8

1.6

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.42

0.39

1.6

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

334

3360

0.95

0.39

1.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.38

0.38

1.1

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

290

0.83

0.38

3.0

3.7

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

163

1.24

0.38

1.1

mg/l

182.2

215.4

0.55

141

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.38

0.38

1.2

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

377

1.15

0.37

1.4

1.3

—

(3025130) Human papilloma virus identified in Specimen

237

0.81

0.37

1.7

—

(3014051) Protein [Presence] in Urine by Test strip

382

0.85

0.37

1.8

1.9

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

540

5030

1.04

0.37

2.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

469

1.13

0.36

1.1

u/ml

1.2

0.3

0.35

186

(3012494) Peanut IgE Ab [Units/volume] in Serum

235

1.19

0.36

1.1

1.3

u/ml

1.7

17.9

0.94

185

(3034426) Prothrombin time (PT)

1.38

0.35

1.0

1.4

—

(3002619) Bacteria identified in Specimen by Culture

1.34

0.34

1.3

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

531

0.89

0.34

1.4

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

642

0.90

0.34

1.6

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1.30

0.34

1.2

1.3

pmol/l

159.0

48.7

—

(3016502) Oxygen saturation in Arterial blood

134

1203

1.08

0.33

8.5

10.2

94.1

95.6

1.01

129

1160

(3000330) Specific gravity of Urine by Test strip

682

0.90

0.33

2.5

2.9

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

131

1.25

0.33

1.7

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

153

1566

0.94

0.33

3.3

2.8

ug/l

0.7

0.8

0.42

106

982

(3002621) Streptococcal DNAse B [Units/volume] in Serum

0.66

0.32

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.36

0.32

2.0

2.5

umol/l

14.4

17.5

—

(3047189) Immunofixation for 24 hour Urine

1.28

0.32

2.3

1.7

—

(3014271) Vancomycin [Susceptibility]

1.28

0.32

3.2

2.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

337

1.14

0.32

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

769

1.09

0.32

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

166

1508

1.06

0.31

1.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

799

1.09

0.30

1.1

1.2

u/ml

2.1

1.1

0.30

506

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

261

0.85

0.29

1.2

1.6

—

1810.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

745

1.09

0.29

1.3

—

(3044941) Cell count panel - Synovial fluid

196

1.18

0.29

1.1

1.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.23

0.29

1.1

—

(3045414) Leukocytes [Presence] in Urine

682

1.09

0.28

1.5

1.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

523

0.90

0.28

1.4

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

785

1.08

0.27

1.1

1.2

u/ml

4.1

3.7

0.06

251

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

126

1.22

0.27

3.2

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

126

1.22

0.27

3.2

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

126

1.22

0.27

3.2

1.7

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

184

1857

0.95

0.27

1.6

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

750

1.08

0.26

1.5

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.30

0.26

1.3

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

109

1.24

0.26

6.9

5.5

—

42.6

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.22

0.25

5.6

5.9

—

(3047181) Lactate [Moles/volume] in Blood

363

1.12

0.25

4.3

7.2

mmol/l

1.3

1.2

0.00

314

(4198724)

172

1.18

0.25

2.0

2.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.26

0.25

1.1

iu/ml

135.8

217.1

1.08

(3045788) Cell count panel - Pleural fluid

1.26

0.25

1.3

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.20

0.25

8.1

3.7

—

(3006462) Nitrate [Presence] in Urine

1.19

0.24

3.9

2.6

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.19

0.24

1.3

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

493

1.10

0.24

2.8

3.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

884

1.07

0.24

1.2

u/ml

1.8

2.7

0.41

521

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.17

0.24

1.3

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.28

0.24

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.28

0.24

1.3

1.1

—

(4027681)

146

1.19

0.24

1.6

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

458

1.09

0.23

1.4

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.27

0.22

6.9

5.9

—

(1002224) Polysomnography panel

534

0.92

0.22

1.1

—

(3011288) Drugs identified in Urine by Screen method

107

973

1.06

0.22

2.6

2.7

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

6.7

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3014891) Appearance of Pleural fluid

0.00

0.21

0.0

1.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.21

0.0

1.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.17

0.21

1.2

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

413

0.91

0.21

1.5

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

0.78

0.21

1.1

1.2

nmol/l

—

1.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

825

1.06

0.20

1.8

1.6

—

(3002523) Influenza virus A Ag [Presence] in Specimen

461

1.09

0.20

1.4

1.2

—

(3009015) Lactate [Moles/volume] in Synovial fluid

0.00

0.20

0.0

1.1

—

7.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.25

0.20

1.3

1.1

—

(40760409) HLA-A [Type] by High resolution

0.00

0.20

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.20

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.20

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.20

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.20

0.0

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

472

1.08

0.19

1.3

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

772

1.06

0.19

1.4

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

449

0.92

0.18

1.3

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

539

1.07

0.18

1.1

u/ml

3.2

7.6

2.26

276

(4094501)

279

1.10

0.18

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

961

0.95

0.17

2.9

2.6

ml/min/173m2

60.9

73.3

1.79

346

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

151

1.15

0.17

1.8

2.4

mmol/l

1.6

2.0

—

121

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.76

0.17

1.2

1.3

—

(3038026) Centromere Ab [Units/volume] in Serum

106

1.18

0.17

1.1

1.2

—

54.2

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

1.15

0.16

3.0

2.4

—

180.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.78

0.15

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

114

1054

1.04

0.14

1.3

1.2

au/ml

53.3

41.0

—

(3024928) Oxygen saturation in Venous blood

384

0.93

0.14

16.8

10.7

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

1.17

0.13

1.3

1.4

e6/l

541.4

46997.9

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

443

1.07

0.13

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

219

1.10

0.13

2.2

2.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

679

1.05

0.13

11.2

13.4

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

104

0.83

0.13

1.3

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

426

1.06

0.12

1.1

1.2

—

(3024471) HLA-A [Type]

100

1.16

0.12

1.0

—

(3024932) HLA-DR beta [Type]

100

1.16

0.12

1.0

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

325

1.07

0.11

1.3

1.4

u/ml

9.7

3.2

1.09

203

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

166

1.10

0.11

1.9

2.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

176

1.09

0.10

2.9

1.8

—

(3044007) Cell count panel - Peritoneal fluid

1.15

0.10

1.6

2.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.12

0.10

1.2

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

102

1.13

0.09

1.1

—

40.7

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

103

1.12

0.08

1.1

1.2

—

69.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

0.79

0.08

2.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

178

1.08

0.08

3.1

3.2

nmol/l

0.9

0.8

0.31

143

(3028707) Methadone [Presence] in Urine by Screen method

657

0.97

0.08

2.6

2.8

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.82

0.07

4.0

2.5

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.82

0.07

8.0

5.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

179

1.08

0.07

1.7

1.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

198

1.07

0.07

1.5

1.4

mmol/l

8.9

11.5

—

(4211845)

1.06

0.07

4.0

2.5

—

(3023410) Appearance of Cerebral spinal fluid

284

0.95

0.06

4.3

3.9

—

(3044927) Protein electrophoresis panel - Urine

101

0.86

0.06

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

180

1.07

0.06

1.7

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

180

1.07

0.06

1.7

1.4

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

1.10

0.05

1.0

1.2

—

4.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

181

1.06

0.05

1.7

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

181

1.06

0.05

1.7

1.4

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

321

0.96

0.05

1.2

1.4

u/ml

3.1

14.0

1.23

184

(3051387) C reactive protein [Mass/volume] in Capillary blood

321

0.96

0.05

4.4

3.1

mg/l

33.4

24.4

0.72

199

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

106

1.09

0.04

1.8

2.4

43.0

43.7

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

1.09

0.04

1.2

1.0

u/l

0.9

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.09

0.04

1.5

—

(3008898) HLA-B27 [Presence]

774

0.98

0.04

1.1

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

259

1.04

0.03

1.0

kpa

3.3

0.09

213

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

183

1.05

0.03

1.7

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

107

1.08

0.03

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

908

0.98

0.03

1.5

1.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

492

0.98

0.03

2.5

1.8

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

117

1.07

0.03

2.1

2.3

—

(3004959) Base excess in Arterial cord blood by calculation

262

1.03

0.01

1.0

mmol/l

-0.7

-1.1

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

262

1.03

0.01

1.0

kpa

7.3

7.2

0.22

216

(3006598) pH of Arterial cord blood

262

1.03

0.01

1.0

—

(3011648) Oxygen content in Venous blood

195

1.04

0.01

21.7

17.5

11.0

11.4

0.19

195

(3035933) Granulocytes/100 leukocytes in Blood

199

0.97

0.01

1.4

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

652

0.99

0.01

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

285

0.98

0.00

1.0

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

544

0.99

0.00

2.7

1.9

—

(3023199) Leukocytes [#/volume] in Pleural fluid

111

1.04

0.00

1.3

1.4

e6/l

901.7

2352.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

149

1.03

0.00

1.4

2.0

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

125

1.00

0.00

2.3

3.5

48.4

54.8

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

338

1.00

0.00

1.5

1.2

—

(4024509)

106

1.00

0.00

1.7

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

104

1.02

0.00

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

1.01

0.00

1.0

1.1

—

(4010399)

103

995

1.00

0.00

1.6

1.4

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

122

1.03

0.00

1.1

1.3

u/ml

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

580

0.99

0.00

1.9

1.6

iu/ml

0.1

0.2

—

121

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

103

1.03

0.00

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

103

1.03

0.00

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

103

1.03

0.00

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

120

0.96

0.00

1.0

—

(42870560) Thyrotropin [Units/volume] in Cord blood

334

1.01

0.00

1.0

mu/l

9.1

8.6

0.10

286

(3041672) Baker's yeast Ab [Presence] in Serum

0.96

0.00

1.0

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.95

0.00

1.7

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

0.94

0.00

1.0

1.1

u/ml

3.8

3.9

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.91

0.00

1.2

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

1.00

0.00

1.0

5.6

—

178.3

—

(3001729) Color of Synovial fluid

0.00

0.0

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.89

0.00

5.5

3.2

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

0.0

1.0

—

(3017497) Pine Nut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.0

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.0

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.87

0.00

1.0

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.0

1.3

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.91

0.00

1.2

1.1

—

(3022670) pH of Venous cord blood

0.96

0.00

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

(3013762) Body weight Measured

0.00

0.0

1.5

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.1

—

8.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.0

3.4

—

(3015183) Erythrocyte sedimentation rate

0.92

0.00

1.0

1.3

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

0.0

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_ENDODIS and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_ENDODIS	2.214 [1.89, 2.6]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.06

During the follow-up period (1.1.1998 — 31.12.2019), 836 out of 14401 females with E4_ENDODIS died.

Males

Parameter	HR [95% CI]	p-value
E4_ENDODIS	2.624 [2.25, 3.06]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.011

During the follow-up period (1.1.1998 — 31.12.2019), 808 out of 12884 males with E4_ENDODIS died.

Mortality risk

Mortality risk for people of age

years, who have E4_ENDODIS.

N-year risk	Females	Males
1	0.208%	0.389%
5	1.229%	2.819%
10	2.919%	6.793%
15	5.687%	13.4%
20	9.654%	22.642%

Relationships between endpoints

↥

Index endpoint: E4_ENDODIS – Other endocrine disorders

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other endocrine disorders

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints